
Corporate Governance28 Apr 2026, 04:41 pm
Speciality Medicines updates KMP contact details for disclosures
AI Summary
Speciality Medicines Ltd has updated the contact details of its Key Managerial Personnel (KMP) responsible for determining the materiality of events and making disclosures to the stock exchanges. This action is in compliance with Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors authorized Mr. Parthkumar Babulal Goyani (Chairman and Managing Director) and Ms. Anita Kumawat (Company Secretary & Compliance Officer) for these roles during a board meeting held on April 28, 2026. The contact information, including phone and email, for Mr. Goyani is provided. The details are also available on the company's website.
Key Highlights
- KMP contact details updated for regulatory compliance.
- Board authorized KMPs for materiality determination and disclosures.
- Mr. Parthkumar Goyani designated for materiality assessment.
- Ms. Anita Kumawat designated for making disclosures.
- Updated details are available on the company's website.
Price Impact
More from SPML